Marco Marra has driven the expansion of genomics in Canada. He led or co-led numerous cancer projects, revealing new mutations, biomarkers, and therapeutic targets in ovarian cancers, B cell lymphomas, brain cancers, breast cancers, medulloblastomas, leukemias, rhabdoid tumours and cervical cancers.